(Q35963400)

11 August 2017

Clinical activity of the MEK inhibitor trametinib in metastatic melanoma containing BRAF kinase fusion (English)

1 reference

11 August 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26072686%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Iwei Yeh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26072686%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Thomas Botton

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26072686%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Boris C. Bastian

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26072686%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Richard Scolyer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26072686%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Georgina V. Long

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26072686%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

6

Georgina V Long

1 reference

11 August 2017

5

Richard A Scolyer

1 reference

11 August 2017

1

Alexander M Menzies

1 reference

11 August 2017

Iwei Yeh

2

1 reference

11 August 2017

Thomas Botton

3

1 reference

11 August 2017

Boris C Bastian

4

1 reference

11 August 2017

15 June 2015

1 reference

Pigment Cell & Melanoma Research

11 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26072686%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26072686%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26072686%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

607-610

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26072686%20AND%20SRC:MED&resulttype=core&format=json

A meta-analysis of somatic mutations from next generation sequencing of 241 melanomas: a road map for the study of genes with potential clinical relevance

13 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4539279

Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4539279

Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4539279

BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4539279

Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4539279

Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4539279

BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4539279

Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4539279

Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4539279

Signalling and chemosensitivity assays in melanoma: is mutated status a prerequisite for targeted therapy?

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26072686

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/PCMR.12388

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26072686%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26072686%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

PubMed publication ID

26072686

1 reference